@theoc, yeah mate, very sketchy collaboration.....couple of interesting points....
1....we retain Efti license.....very important for us good guys.
2...US trials mooted yet immutep hasn't been approved to conduct US trials as yet....
3....Does that mean trial conducted under Merck license?
4...Ridgeback and Lucy up the anti a bit, thus making it harder for a hostile takeover.
Nasdaq likely to take Holman's "renewed" interest favourably.
5....Merck interest will go very well in the biotech industry, expect some very positive
news items in the next few days...
6....You would have to think that Merck interest is because of Tacti-mel, a
Prima biomed/Immutep iniative where phase 1 results are imminent..In my
mind that means Tactimel will progress to ph2....
Take what I say with a grain of salt......
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep enters into collaboration with MSD
Ann: Immutep enters into collaboration with MSD, page-33
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.5¢ | 40.5¢ | 39.5¢ | $998.2K | 2.495M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7607 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 36888 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1942 | 0.400 |
1 | 30000 | 0.395 |
3 | 138000 | 0.390 |
3 | 18064 | 0.385 |
9 | 217762 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 94 | 1 |
0.400 | 3400 | 1 |
0.405 | 130000 | 2 |
0.410 | 200033 | 6 |
0.415 | 220895 | 9 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |